BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,640,453 | -20.8% | 281,941 | -4.4% | 0.04% | -15.6% |
| Q2 2023 | $13,439,061 | +12.3% | 294,975 | 0.0% | 0.04% | +4.7% |
| Q1 2023 | $11,964,186 | -18.1% | 294,975 | +2.9% | 0.04% | -21.8% |
| Q4 2022 | $14,613,354 | -5.4% | 286,705 | 0.0% | 0.06% | -11.3% |
| Q3 2022 | $15,442,000 | -16.1% | 286,705 | 0.0% | 0.06% | -11.4% |
| Q2 2022 | $18,415,000 | -17.6% | 286,705 | -0.6% | 0.07% | -1.4% |
| Q1 2022 | $22,360,000 | -9.7% | 288,365 | 0.0% | 0.07% | -1.4% |
| Q4 2021 | $24,753,000 | +5.9% | 288,365 | -0.7% | 0.07% | 0.0% |
| Q3 2021 | $23,368,000 | -1.5% | 290,542 | -1.4% | 0.07% | -7.7% |
| Q2 2021 | $23,719,000 | -8.2% | 294,645 | -3.8% | 0.08% | -14.3% |
| Q1 2021 | $25,834,000 | -0.1% | 306,312 | -4.9% | 0.09% | 0.0% |
| Q4 2020 | $25,852,000 | -4.4% | 322,188 | -4.2% | 0.09% | -15.0% |
| Q3 2020 | $27,053,000 | -11.6% | 336,395 | -5.4% | 0.11% | -16.4% |
| Q2 2020 | $30,601,000 | +4.9% | 355,413 | -1.1% | 0.13% | -9.2% |
| Q1 2020 | $29,172,000 | -2.9% | 359,310 | 0.0% | 0.14% | +24.8% |
| Q4 2019 | $30,046,000 | -11.2% | 359,310 | -7.1% | 0.11% | -13.1% |
| Q3 2019 | $33,833,000 | -24.9% | 386,800 | -29.7% | 0.13% | -22.6% |
| Q2 2019 | $45,045,000 | +0.7% | 550,000 | 0.0% | 0.17% | +0.6% |
| Q1 2019 | $44,721,000 | +23.5% | 550,000 | 0.0% | 0.17% | +7.7% |
| Q4 2018 | $36,201,000 | +1465.1% | 550,000 | +1733.3% | 0.16% | +1622.2% |
| Q3 2018 | $2,313,000 | +4.4% | 30,000 | 0.0% | 0.01% | +12.5% |
| Q2 2018 | $2,215,000 | +13.5% | 30,000 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $1,951,000 | -76.9% | 30,000 | -85.4% | 0.01% | -78.9% |
| Q1 2016 | $8,462,000 | -46.2% | 206,000 | -50.0% | 0.04% | +15.2% |
| Q4 2015 | $15,718,000 | +53.9% | 412,000 | +32.5% | 0.03% | -23.3% |
| Q3 2015 | $10,216,000 | -53.0% | 311,000 | 0.0% | 0.04% | -48.8% |
| Q2 2015 | $21,748,000 | -10.8% | 311,000 | -12.6% | 0.08% | -11.6% |
| Q1 2015 | $24,386,000 | -6.5% | 356,000 | 0.0% | 0.10% | -5.9% |
| Q4 2014 | $26,091,000 | +2.1% | 356,000 | 0.0% | 0.10% | 0.0% |
| Q3 2014 | $25,550,000 | -0.7% | 356,000 | 0.0% | 0.10% | -1.0% |
| Q2 2014 | $25,739,000 | – | 356,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |